{"entity":{"id":"natureceuticals","kind":"company","name":"NatureCeuticals","aka":["Natureceuticals Sdn Bhd"],"tldr":"NatureCeuticals is a Malaysia-based biotechnology company that leads 3 cancer trials in OnCo, testing the botanical medicine Nuvastatic for cancer-related fatigue in colorectal cancer and triple-negative breast cancer.","summary":"NatureCeuticals is a Malaysian clinical-stage company developing standardised botanical medicines for supportive and adjunctive cancer care. Its lead product Nuvastatic, based on Orthosiphon stamineus leaf extract, is in phase 3 trials for cancer-related fatigue in patients receiving chemotherapy for colorectal and triple-negative breast cancer. On ClinicalTrials.gov it is the lead sponsor of 3 trials recorded in OnCo (3 in phase 3 or 2/3): NCT07669454 (phase 3, A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III...), NCT07669519 (phase 3, Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients...) and NCT07669467 (phase 3, Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.ncnatureceuticals.com/"},{"label":"ClinicalTrials.gov: trials led by NatureCeuticals","url":"https://clinicaltrials.gov/search?lead=Natureceuticals%20Sdn%20Bhd"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["colorectal","tnbc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct07669454","nct07669519","nct07669467"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Kuala Lumpur","country":"MY","companyType":"biotech","website":"https://www.ncnatureceuticals.com/","stage":"growth","investors":[],"funding":[]},"route":"/companies/natureceuticals/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"trial":[{"id":"nct07669454","kind":"trial","name":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.","route":"/trials/nct07669454/"},{"id":"nct07669519","kind":"trial","name":"Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy","route":"/trials/nct07669519/"},{"id":"nct07669467","kind":"trial","name":"Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer","route":"/trials/nct07669467/"}]}}